Acutaas Chemicals Ltd Gains 4.20%: 7 Key Factors Driving the Rally

1 hour ago
share
Share Via
Acutaas Chemicals Ltd delivered a strong weekly performance, rising 4.20% from Rs.2,158.70 to Rs.2,249.35 between 2 and 6 March 2026, significantly outperforming the Sensex which declined 3.00% over the same period. The stock hit multiple new 52-week and all-time highs during the week, supported by robust financial results, operational efficiency, and strong institutional backing amid a volatile broader market environment.

Key Events This Week

2 Mar: Stock opens week at Rs.2,191.20 with 1.51% gain despite Sensex decline

4 Mar: New 52-week and all-time high at Rs.2,208.15 amid sector volatility

5 Mar: Further all-time high at Rs.2,213.25 and 52-week high at Rs.2,227.90

6 Mar: Week closes at all-time high Rs.2,268, marking sustained momentum

Week Open
Rs.2,158.70
Week Close
Rs.2,249.35
+4.20%
Week High
Rs.2,268
Sensex Change
-3.00%

2 March 2026: Strong Start Despite Market Weakness

Acutaas Chemicals Ltd began the week on a positive note, closing at Rs.2,191.20, up 1.51% from the previous close of Rs.2,158.70. This gain was notable as the Sensex fell sharply by 1.41% to 35,812.02. The stock’s outperformance reflected investor confidence in its strong fundamentals and growth prospects, as highlighted by its multibagger returns exceeding 100% over the past year and a robust Mojo Score of 82.0 with a Strong Buy rating from MarketsMOJO.

4 March 2026: New 52-Week and All-Time High Amid Sector Volatility

On 4 March, Acutaas Chemicals Ltd reached a new 52-week and all-time high of Rs.2,208.15, despite closing the day down 3.97% at Rs.2,104.10. The stock opened with a gap down of 2.5% and touched an intraday low of Rs.2,085.40, reflecting short-term consolidation after a strong rally. The broader market was volatile, with the Sensex declining 1.92% to 35,125.64. The stock’s ability to maintain levels above key moving averages indicated underlying strength amid the pullback.

5 March 2026: Surge to New Highs on Strong Volume

Acutaas Chemicals Ltd rebounded sharply on 5 March, surging 6.20% to close at Rs.2,234.50, surpassing the previous day’s highs and setting a new 52-week high of Rs.2,227.90 and an all-time high intraday price of Rs.2,213.25. This rally outpaced the Sensex’s 1.29% gain to 35,579.03. The stock’s strong performance was supported by robust quarterly net sales of Rs.393.18 crores, a 43.4% increase over the prior four-quarter average, and continued operational efficiency with a ROCE of 21.30% and low debt-to-equity ratio.

While markets shift, this one's charging ahead! This Micro Cap from Aquaculture shows the strongest momentum signals in current conditions. Don't miss out on this ride!

  • - Strongest current momentum
  • - Market-cycle outperformer
  • - Aquaculture sector strength

Don't Miss This Ride →

6 March 2026: Week Closes at Record High Amid Mixed Market

The stock continued its upward momentum on 6 March, hitting a new 52-week and all-time high of Rs.2,268 before closing at Rs.2,249.35, up 0.66% on the day. This marked a cumulative weekly gain of 4.20%, contrasting with the Sensex’s 3.00% decline to 35,232.05. Despite a broadly negative market environment, Acutaas Chemicals demonstrated resilience, maintaining levels above all key moving averages and supported by strong institutional ownership of 38.38%.

Daily Price Comparison: Acutaas Chemicals Ltd vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-03-02 Rs.2,191.20 +1.51% 35,812.02 -1.41%
2026-03-04 Rs.2,104.10 -3.97% 35,125.64 -1.92%
2026-03-05 Rs.2,234.50 +6.20% 35,579.03 +1.29%
2026-03-06 Rs.2,249.35 +0.66% 35,232.05 -0.98%

Key Takeaways from the Week

Robust Financial Growth: Acutaas Chemicals Ltd’s net sales grew at an annualised rate of 26.84%, with operating profit expanding 38.56% and net profit surging 47.82%, supported by six consecutive quarters of positive earnings.

Strong Operational Metrics: The company’s ROCE of 21.30%, inventory turnover ratio of 5.74 times, and debtors turnover ratio of 3.76 times highlight efficient capital utilisation and working capital management.

Premium Valuation Backed by Earnings Growth: Despite a high price-to-book ratio of 12.1–13 and a P/E ratio of 61.11, the PEG ratio of 0.4–0.5 suggests earnings growth outpaces valuation, justifying the premium.

Institutional Confidence: Significant institutional ownership at 38.38% underpins market stability and reflects strong analytical endorsement.

Market Outperformance: The stock outperformed the Sensex by over 7 percentage points this week, continuing a trend of sustained market-beating returns over one, three, and twelve-month periods.

Technical Strength: Trading above all key moving averages and hitting multiple new highs signals strong momentum and investor confidence.

Short-Term Volatility: The dip on 4 March amid sector weakness suggests some consolidation, but the swift recovery on 5 March indicates resilience.

Thinking about Acutaas Chemicals Ltd? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this small-cap stock!

  • - Real-time Verdict available
  • - Financial health breakdown
  • - Fair valuation calculated

Check the Verdict Now →

Conclusion

Acutaas Chemicals Ltd’s performance during the week of 2 to 6 March 2026 highlights its position as a resilient and high-growth stock within the Pharmaceuticals & Biotechnology sector. The stock’s ability to hit multiple new 52-week and all-time highs amid a broadly negative market environment underscores strong investor confidence and robust fundamentals. Supported by consistent earnings growth, operational efficiency, and significant institutional backing, the company continues to demonstrate market leadership and sustained momentum. While valuation metrics indicate a premium, the company’s earnings growth and financial discipline provide a solid foundation for its current market standing. Investors monitoring this stock should note its strong technical positioning and continued outperformance relative to benchmark indices.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News